Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

$3.7B

Market Cap • 2/4/2025

2014

(11 years)
Founded

2022

(3 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Redwood

Headquarters • California